chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: chills; headache; body aches, stayed in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches, stayed in bed all day) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Encephalitis autoimmune. Previously administered products included for Product used for unknown indication: Johnson and Johnson vaccine (Second dose) and Johnson and Johnson vaccine (First dose). Past adverse reactions to the above products included No adverse event with Johnson and Johnson vaccine and Johnson and Johnson vaccine.    On 26-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Nov-2021, the patient experienced CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches, stayed in bed all day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Chills, Myalgia and Headache, at an unspecified dose and frequency. On 28-Nov-2021, CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches, stayed in bed all day) had resolved.            No concomitant medications were reported.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No Treatment information was provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.  The patient was monitored for at least 15 minutes after the injection with no adverse events. reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vials were expired) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vials were expired). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (The vials were expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: potentially received expired dose (past 30 days in refrigerator); potentially received expired dose (past 30 days in refrigerator); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (potentially received expired dose (past 30 days in refrigerator)) and PRODUCT STORAGE ERROR (potentially received expired dose (past 30 days in refrigerator)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (potentially received expired dose (past 30 days in refrigerator)) and PRODUCT STORAGE ERROR (potentially received expired dose (past 30 days in refrigerator)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (potentially received expired dose (past 30 days in refrigerator)) and PRODUCT STORAGE ERROR (potentially received expired dose (past 30 days in refrigerator)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: significant follow-up appended on 01-dec-2021: individual patients details and drug details
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. No temperature excursions. Dose administered after 30-day Use By Date or after manufacturer date of expiry. Patient were monitored for at least 15 minutes after the injection with no adverse events reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No Treatment information was provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported   No treatment information was provided  All patients were monitored for at least 15 minutes after the injection with no adverse events reported.    This case was linked to MOD-2021-403245 (Patient Link).
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vials were expired; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vials were expired) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vials were expired). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vials were expired) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.  All patients were monitored for at least 15 minutes after the injection with no adverse events reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 19 patients received an expired booster; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was monitored for at least 15 minutes after the injection with no adverse events reported.  No concomitant medications were reported.  No treatment medications were reported.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 19 patients received an expired booster; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered 12 hours post puncture.) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered 12 hours post puncture.). On 01-Dec-2021, EXPIRED PRODUCT ADMINISTERED (dose administered 12 hours post puncture.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Vaccination complication
Clinical narrative: incapacitated; a little reaction; fatigue; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA, VACCINATION COMPLICATION, FATIGUE, CHILLS, and HEADACHE in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced ASTHENIA, VACCINATION COMPLICATION, FATIGUE, CHILLS, and HEADACHE. At the time of the report, ASTHENIA outcome was unknown and VACCINATION COMPLICATION, FATIGUE, CHILLS, and HEADACHE had resolved.            No concomitant and treatment information were reported by the reporter    This case was linked to MOD-2021-402915, MOD-2021-403232 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Rash, Vaccination site mass
Clinical narrative: arm rash that got larger then eventually subsided; right arm was red; "apricot" like lump at the injection site "like a bolus in the muscle"; "injection site reaction"; right arm was itchy; right arm was hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION, PRURITUS, FEELING HOT, RASH, and ERYTHEMA in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Nov-2021, the patient experienced VACCINATION SITE REACTION, PRURITUS, FEELING HOT, ERYTHEMA, and VACCINATION SITE MASS. On 28-Nov-2021, the patient experienced RASH. On 30-Nov-2021, PRURITUS outcome was unknown, FEELING HOT, ERYTHEMA, and VACCINATION SITE MASS had resolved. At the time of the report, VACCINATION SITE REACTION outcome was unknown and RASH had resolved.            No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-403231, MOD-2021-402915 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: arm rash that got larger then eventually subsided; right arm was red; "apricot" like lump at the injection site "like a bolus in the muscle"; "injection site reaction"; right arm was itchy; right arm was hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION, PRURITUS, FEELING HOT, RASH, and ERYTHEMA in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Nov-2021, the patient experienced VACCINATION SITE REACTION, PRURITUS, FEELING HOT, ERYTHEMA, and VACCINATION SITE MASS. On 28-Nov-2021, the patient experienced RASH. On 30-Nov-2021, PRURITUS outcome was unknown, FEELING HOT, ERYTHEMA, and VACCINATION SITE MASS had resolved. At the time of the report, VACCINATION SITE REACTION outcome was unknown and RASH had resolved.            No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-403231, MOD-2021-402915 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Subcutaneous abscess
Clinical narrative: Abscess in the back.; This spontaneous case was reported by a consumer and describes the occurrence of SUBCUTANEOUS ABSCESS (Abscess in the back.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Nov-2021, the patient experienced SUBCUTANEOUS ABSCESS (Abscess in the back.). The patient was treated with DOXYCYCLINE for Back abscess, at a dose of bid, for a week. At the time of the report, SUBCUTANEOUS ABSCESS (Abscess in the back.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Osteoarthritis
Clinical narrative: After my 2nd shot I have developed Osteoarthritis; This spontaneous case was reported by an other health care professional and describes the occurrence of OSTEOARTHRITIS (After my 2nd shot I have developed Osteoarthritis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OSTEOARTHRITIS (After my 2nd shot I have developed Osteoarthritis). At the time of the report, OSTEOARTHRITIS (After my 2nd shot I have developed Osteoarthritis) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise, Pyrexia
Clinical narrative: didn't feel good overall; was shaky; fever; chills; very tired; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills) and FATIGUE (very tired) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Seasonal allergy, OMEPRAZOLE for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Dec-2020, the patient experienced MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills), FATIGUE (very tired) and HEADACHE (headache). At the time of the report, MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills), FATIGUE (very tired) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-402910, MOD-2021-403241 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: didn't feel good overall; was shaky; fever; chills; very tired; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills) and FATIGUE (very tired) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Seasonal allergy, OMEPRAZOLE for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Dec-2020, the patient experienced MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills), FATIGUE (very tired) and HEADACHE (headache). At the time of the report, MALAISE (didn't feel good overall), TREMOR (was shaky), PYREXIA (fever), CHILLS (chills), FATIGUE (very tired) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-402910, MOD-2021-403241 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Eructation, Nausea, Pain in extremity, Pyrexia
Clinical narrative: stomach was very upset , stomach is so bad; patient reported to be burping a lot and burped during the call, nothing is helping; hand started hurting; nauseated, I feels like vomiting but can't vomit; feverish after the booster too; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach was very upset , stomach is so bad), ERUCTATION (patient reported to be burping a lot and burped during the call, nothing is helping), PAIN IN EXTREMITY (hand started hurting), NAUSEA (nauseated, I feels like vomiting but can't vomit) and PYREXIA (feverish after the booster too) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011520A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal), Gas and Anxiety. Concomitant products included PANTOPRAZOLE for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach was very upset , stomach is so bad), ERUCTATION (patient reported to be burping a lot and burped during the call, nothing is helping), PAIN IN EXTREMITY (hand started hurting), NAUSEA (nauseated, I feels like vomiting but can't vomit) and PYREXIA (feverish after the booster too). The patient was treated with FAMOTIDINE for Nausea, at a dose of 20 mg. At the time of the report, ABDOMINAL DISCOMFORT (stomach was very upset , stomach is so bad), ERUCTATION (patient reported to be burping a lot and burped during the call, nothing is helping), PAIN IN EXTREMITY (hand started hurting), NAUSEA (nauseated, I feels like vomiting but can't vomit) and PYREXIA (feverish after the booster too) outcome was unknown.            This case was linked to MOD-2021-403284 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Influenza
Clinical narrative: feel like I have the flu; sharp pains in my chest; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (feel like I have the flu) and CHEST PAIN (sharp pains in my chest) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced INFLUENZA (feel like I have the flu) and CHEST PAIN (sharp pains in my chest). At the time of the report, INFLUENZA (feel like I have the flu) and CHEST PAIN (sharp pains in my chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: Sore arm; headache; body aches; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and MYALGIA (body aches) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (patient was diagnosed with Covid-19 twice, before receiving her 1st dose of vaccine). Concurrent medical conditions included Asthma.   On 14-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and MYALGIA (body aches). At the time of the report, PAIN IN EXTREMITY (Sore arm), HEADACHE (headache) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported   No treatment information was provided   This case was linked to MOD-2021-403245 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Endocrine disorder (Endocrine insufficient). Concomitant products included HYDROCORTISONE for Endocrine disorder.   On 25-Feb-1900, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) outcome was unknown.            No treatment medications were reported.   This case was linked to MOD-2021-403248, MOD-2021-403252 (Patient Link).
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: child who is 9 years old received Moderna booster; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (child who is 9 years old received Moderna booster) in a 9-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 01-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (child who is 9 years old received Moderna booster). On 01-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (child who is 9 years old received Moderna booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter. No treatment medications were reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: arm pain; slight chills; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm pain) and CHILLS (slight chills) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain) and CHILLS (slight chills). At the time of the report, PAIN IN EXTREMITY (arm pain) and CHILLS (slight chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-403262, MOD-2021-403028 (Patient Link).
Sex: M
Vaccine: COVID19, UNK
Symptoms: Mobility decreased, Muscular weakness, Pain
Clinical narrative: Unable to move; Muscle weakness; Body ache/ pain; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Unable to move), MUSCULAR WEAKNESS (Muscle weakness) and PAIN (Body ache/ pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RUXOLITINIB PHOSPHATE (JAKAFI) for Polycythaemia vera.    Concomitant products included APIXABAN (ELIQUIS), SIMVASTATIN, NADOLOL, FUROSEMIDE, PANTOPRAZOLE and SPIRONOLACTONE for an unknown indication.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and RUXOLITINIB PHOSPHATE (JAKAFI) (Oral) 5 milligram twice a day. On an unknown date, the patient experienced MOBILITY DECREASED (Unable to move), MUSCULAR WEAKNESS (Muscle weakness) and PAIN (Body ache/ pain). At the time of the report, MOBILITY DECREASED (Unable to move), MUSCULAR WEAKNESS (Muscle weakness) and PAIN (Body ache/ pain) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was reported. Patient had experienced split 10 mg tablets because he ran out of 5 mg, wrong technique in product usage processing regarding jakafi.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia, Temperature difference of extremities
Clinical narrative: Hot Arms & legs; Chills; Fever 99.8 F; Tired; This spontaneous case was reported by a consumer and describes the occurrence of TEMPERATURE DIFFERENCE OF EXTREMITIES (Hot Arms & legs), CHILLS (Chills), PYREXIA (Fever 99.8 F) and FATIGUE (Tired) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0139904 and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, the patient experienced TEMPERATURE DIFFERENCE OF EXTREMITIES (Hot Arms & legs), CHILLS (Chills), PYREXIA (Fever 99.8 F) and FATIGUE (Tired). On 04-Nov-2021, TEMPERATURE DIFFERENCE OF EXTREMITIES (Hot Arms & legs), CHILLS (Chills) and PYREXIA (Fever 99.8 F) had resolved. On 06-Nov-2021, FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Nov-2021, Body temperature: 99.8 (High) 99.8 F.         No concomitant medications information was not reported No treatment medications were provided    This case was linked to MOD-2021-403266 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little bit of pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little bit of pain in the arm) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Immunodeficiency.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of pain in the arm). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (little bit of pain in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-403264, MOD-2021-403267 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: No new information.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Vaccination complication
Clinical narrative: strong reaction; aches; chills; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (strong reaction), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced VACCINATION COMPLICATION (strong reaction), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, VACCINATION COMPLICATION (strong reaction), PAIN (aches), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.   This case was linked to MOD-2021-403265 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue
Clinical narrative: drops came out while giving the vaccine\more than 1 vaccine drop came out because muscle pushes vaccine out; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (drops came out while giving the vaccine\more than 1 vaccine drop came out because muscle pushes vaccine out) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Nov-2021, the patient experienced DEVICE CONNECTION ISSUE (drops came out while giving the vaccine\more than 1 vaccine drop came out because muscle pushes vaccine out). On 30-Nov-2021, DEVICE CONNECTION ISSUE (drops came out while giving the vaccine\more than 1 vaccine drop came out because muscle pushes vaccine out) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported. Treatment medications was not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 5 doses administered more than 12 hours after 1st puncture of the vials; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 doses administered more than 12 hours after 1st puncture of the vials) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Sep-2021 at 4:28 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021 at 4:28 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 doses administered more than 12 hours after 1st puncture of the vials). On 01-Sep-2021 at 4:28 PM, EXPIRED PRODUCT ADMINISTERED (5 doses administered more than 12 hours after 1st puncture of the vials) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  On 17-Aug-2021, the vial was initially stored in the refrigerator and on 31-Aug-2021 at 8:15 am, the vial was first punctured. On 01-Sep-2021 at 4:28 pm, vaccine was administered.   Treatment information was not reported.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Low fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY, PYREXIA, and FATIGUE in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY, PYREXIA, and FATIGUE. On 09-Feb-2021, PAIN IN EXTREMITY, PYREXIA, and FATIGUE had resolved.            No concomitant medication was provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-403266, MOD-2021-403257 (Patient Link).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little bit of pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little bit of pain in the arm) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Immunodeficiency.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of pain in the arm). At the time of the report, PAIN IN EXTREMITY (little bit of pain in the arm) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-403258 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: Non-Significant Follow up-Document attached
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in jaw, Vaccination site pain
Clinical narrative: pain in jaw bone; pain in the area of the injection site/still has pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (pain in jaw bone) and VACCINATION SITE PAIN (pain in the area of the injection site/still has pain in the arm) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 013A21A and 028A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Immunodeficiency.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced PAIN IN JAW (pain in jaw bone) and VACCINATION SITE PAIN (pain in the area of the injection site/still has pain in the arm). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN JAW (pain in jaw bone) had resolved and VACCINATION SITE PAIN (pain in the area of the injection site/still has pain in the arm) had not resolved.            No concomitant medication details was provided.   This case was linked to MOD-2021-403258 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: Follow up received on 30-NOV-2021 included No New Information
Sex: U
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: swelling of the wrist; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling of the wrist) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (swelling of the wrist). At the time of the report, JOINT SWELLING (swelling of the wrist) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided. No treatment medications were provided. It was reported that the swelling subsided after 4-5 months.   This case was linked to MOD21-117465, MOD21-168413, MOD21-168423, MOD21-168424 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-117465: MOD21-168413: MOD21-168423: MOD21-168424:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (60 patients received doses that were past the storage conditions) and EXPIRED PRODUCT ADMINISTERED (patients were receiving doses that were stored for too long) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (60 patients received doses that were past the storage conditions) and EXPIRED PRODUCT ADMINISTERED (patients were receiving doses that were stored for too long). At the time of the report, PRODUCT STORAGE ERROR (60 patients received doses that were past the storage conditions) and EXPIRED PRODUCT ADMINISTERED (patients were receiving doses that were stored for too long) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medication were reported no treatment medication were reported
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Pyrexia, Vaccination complication
Clinical narrative: "normal sort of side effects"; Fatigue; Mild fever after those; Pain at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION ("normal sort of side effects"), FATIGUE (Fatigue), PYREXIA (Mild fever after those) and INJECTION SITE PAIN (Pain at the injection site) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cold sores. Concomitant products included VALACYCLOVIR [VALACICLOVIR] for Cold sores, SERTRALINE HYDROCHLORIDE (SERTRALINE [SERTRALINE HYDROCHLORIDE]) and ATORVASTATIN CALCIUM (ATORVASTATIN [ATORVASTATIN CALCIUM]) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION ("normal sort of side effects"), FATIGUE (Fatigue), PYREXIA (Mild fever after those) and INJECTION SITE PAIN (Pain at the injection site). At the time of the report, VACCINATION COMPLICATION ("normal sort of side effects"), FATIGUE (Fatigue) and PYREXIA (Mild fever after those) outcome was unknown and INJECTION SITE PAIN (Pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was calling on behalf of the patient who after the first vaccine, had normal sort of side effects pain at the injection site, which was temporary and experienced fatigue, mild fever after those and did not have any cutaneous reactions to the dose.  No treatment information was provided.   This case was linked to MOD-2021-402965, MOD-2021-403274, MOD-2021-402691 (Patient Link).